Delphinus Medical Technologies, a groundbreaking innovator in medical imaging, has announced the deployment of its cutting-edge SoftVue™ Breast Ultrasound Tomography (UST) system at McLeod Regional Medical Center in Florence, S.C. This installation marks a significant advancement in breast imaging technology aimed at improving care standards for women with dense breast tissue.
“McLeod Regional Medical Center is joining a growing number of healthcare facilities that recognize the critical need to enhance care for women with dense breasts, and SoftVue represents a pivotal solution in this regard,” stated Scott White, CEO of Delphinus Medical Technologies.
SoftVue UST is distinguished as the sole imaging modality tailored to enhance cancer detection in women with dense breasts. It holds the unique distinction of FDA approval for same-day screening alongside mammography. Designed as a complement to mammography, SoftVue addresses the challenge that traditional mammography alone reduces mortality by 41% in women with non-dense breasts, but only by 13% in those with dense breasts.
Dr. W. Shawn Conwell, MD, FACR, Medical Director of Breast and Women’s Imaging at McLeod Regional Medical Center, emphasized, “Mammogram screening has long been hindered by the complexities of breast tissue density. The denser the breast tissue, the more difficult it is to identify abnormalities—a bit like finding a polar bear in a snowstorm.”
SoftVue significantly enhances sensitivity by 20% and specificity by eight percent when combined with mammography, facilitating comprehensive breast tissue characterization during screening. Dr. Conwell highlighted SoftVue’s capability to conduct whole breast ultrasound tomography in a controlled, reproducible environment. The system captures and archives images of the entire breast, facilitating comparison with prior exams to detect changes over time.
Moreover, SoftVue surpasses standard ultrasound technology by providing multi-dimensional images that overlay critical data to generate a detailed tissue character map of the breast. This advanced capability enables clinicians to distinguish between dense tissue, benign lesions, cysts, and potentially cancerous masses.
Scott White added, “McLeod Regional Medical Center’s adoption of SoftVue underscores its commitment to advancing care for women with dense breasts. We are honored to collaborate with McLeod to bring the benefits of SoftVue to women across the southern region, served by this forward-thinking institution.”
